Final

Communications
Plan Report
Agenda

Revisit Problems Solution Objective

Measures of Communication
Implementation
Success Plan

Cost
What needs Fixing?

Our Negative Perceptions

Pharmaceutical
Monopoly
Industry

Insurance
Drug Uncertainty
Companies
Restoring a Neutral Image

.Employees Patients Investors

Public Relations
Campaign
Giving Back With Genentech

Work Hard. Play Hard. Give Back.

https://www.google.com/search?q=genentech+concert&source=lnms&tbm=isch&sa=X&ved=0ahUKEwjKy4T33P
3WAhXJzlQKHfntAx4Q_AUIDCgD&biw=1257&bih=635
Converting to Net Zero Energy

LEED Silver
https://www.google.com/search?biw=1257&bih=635&tbm=isch&sa=1&q=genentech+campus&oq=genentech+campus&gs_l
=psy-ab.3..0l3j0i30k1j0i24k1l6.31046.33500.0.33716.11.11.0.0.0.0.135.932.8j3.11.0....0...1.1.64.psy-ab..0.11.930...0i13k1j0
i5i30k1.0.mrzshuAuAB4#imgrc=IsUAGQtRVHR8-M:
 Increasing Patient Trust
Three Recent Coverage about Genentech

https://www.gene.com/media

https://finance.yahoo.com/news/genentech-pr
esent-ocrevus-ocrelizumab-efficacy-0500005
19.html
Utilizing Narrative Transportation Theory

Obamacare Speech

Affordable Care Act Saved My Life.

https://www.youtube.com/watch?v=gKxsLxM7abA&t=142s
 Releasing Video Testimonials
Step 1 Step 2 Step 3

Video Make consumers Other consumers

Testimonials- produce a vivid will reflect the
Empathy imagery and attitudes and
Characters- self-identify with intentions of
Patients who the Patients. Patients.
experienced life
changing results.
Partnering with Make a Wish
To grant the wishes
of children with
life-threatening
medical conditions to
enrich the human
experience with hope,
strength and joy.
Bringing Awareness to
Financial Assistance
Communicating with Our
Investors

Highlight sales

Dispel Rumors

Introduce New
Innovations and
Therapies

https://www.roche.com/investors/updates/inv-update-2017-10-19.htm
Appreciating Our Investors

Annual Investor Day

Build Relationships

Showcase New
Innovations
 Showcasing Our Innovations
Provide Bi-Annual Tours of Research and Development Facilities

Initiate meetings with Directors and Lead Scientists

Achieving Neutrality